Yeast Patents (Class 424/93.51)
-
Publication number: 20110189244Abstract: The invention relates to a coating composition for application to a veterinary pharmaceutical composition for oral administration, by a film coating method, comprising a powder appetising material a binder and a solvent. The invention further relates to a coating method by film coating of a solid veterinary pharmaceutical for oral administration and appetising medicaments for animals comprising a veterinary pharmaceutical composition and an appetising coating arranged around said composition, comprising an appetising material and a binder.Type: ApplicationFiled: July 23, 2009Publication date: August 4, 2011Applicant: VIRBACInventors: Guy Derrieu, David Corvaisier
-
Publication number: 20110171187Abstract: The present invention provides a dietary supplement that promote the growth, repair, and maintenance of mammalian bone and joint connective tissue. In particular, the dietary supplement comprises a combination of at least one metal chelate and at least one chondroprotective agent.Type: ApplicationFiled: May 30, 2008Publication date: July 14, 2011Applicant: Novus International, Inc.Inventors: Jeremy D. Moore, Thomas R. Hampton, Robert Harrell
-
Publication number: 20110150853Abstract: A composition comprising an enzyme, a mycotoxin-binding agent and a microorganism capable of taking up a mycotoxin.Type: ApplicationFiled: November 1, 2007Publication date: June 23, 2011Inventors: Stephen Philip Mann, David Parfitt
-
Publication number: 20110135616Abstract: The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.Type: ApplicationFiled: December 7, 2010Publication date: June 9, 2011Inventors: Philippe GIRARD, Marie-Emmanuelle Le Guern, Marc Verleye, Bernard Hublot
-
Patent number: 7951363Abstract: The present invention relates to an ecological protected material, comprising a base material (4) provided with a water-insoluble substance, a growth substrate and a microorganism layer. The invention further relates to a method for preparing a material according to the invention, comprising providing a base material with a water-insoluble substance, a growth substrate and a microorganism.Type: GrantFiled: December 1, 2004Date of Patent: May 31, 2011Assignee: Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNOInventor: Michael Fritz Sailer
-
Publication number: 20110123501Abstract: The present invention relates to supporting weight management, weight loss and/or to the prevention and/or treatment of metabolic disorders. In particular the present invention relates to preventing and/or treating metabolic disorders by modulating, in particular reducing the amount of proteobacteria and/or deferribacteres in the gut. One embodiment of the present invention relates to the use of a primary composition comprising an agent that reduces the amount of proteobacteria, preferably gamma-proteobacteria, even more preferred enterobacteria; and/or deferribacteres in the gut for the preparation of a composition to treat or prevent metabolic disorders, to support weight loss and/or to support weight management.Type: ApplicationFiled: July 25, 2008Publication date: May 26, 2011Applicant: NESTEC S.A.Inventors: Chieh Jason Chou, David Philippe, Christian Darimont, Fabrizio Arigoni, Catherine Mace
-
Publication number: 20110117068Abstract: Described are microorganism which are able to reduce the generation of feces odor by decreasing the amount of at least one of the compounds methyl mercaptan, a sulphide compound, cadavarine, putrescine, indole or skatole, and wherein said decrease in the amount of said compounds is independent of the growth of the microorganism. Also described are compositions, comprising such microorganisms, e.g. food, feed or pharmaceutical compositions and the use of such microorganisms for suppressing feces odor or the preparation of foodstuff or feedstuff, as well as corresponding methods for the production of food or feed composition and additives for food, feed or drinks.Type: ApplicationFiled: August 20, 2007Publication date: May 19, 2011Applicant: OrganoBalance GmbHInventors: Christine Lang, Stefanie Arya, Natalia Bolotina, Markus Veen, Mewes Böttner, Eckhard Budde, Andreas Künkel, Angelika-Maria Pfeiffer
-
Publication number: 20110117194Abstract: The present invention provides a pharmaceutical formulation containing an angiotensin-II receptor blocker and a release-control material as a pharmacologically active ingredient and a pharmaceutical formulation comprising an immediate-release compartment and an extended-release compartment. The immediate-release compartment contains an agent as a pharmacologically active ingredient for preventing and inhibiting hepatitis and the extended-release compartment has an angiotensin-II receptor blocker as a pharmacologically active ingredient. The formulation of the present invention maximizes the effectiveness on pharmacologically and clinically lowering blood pressure and preventing complications when taking the formulation, helps to avoid interaction with a drug which is metabolized by the same enzyme in the liver, and prevents and inhibits the incidence of drug-induced hepatitis which is caused by drug administration for a long time.Type: ApplicationFiled: April 28, 2009Publication date: May 19, 2011Applicant: HANALL BIOPHARMA CO., LTD.Inventors: Sung Wuk Kim, Sung Soo Jun, Young Gwan Jo, Ja Seong Koo, Ah Ram Lee, Jae Woon Son, Jeong Taek Kim
-
Publication number: 20110110907Abstract: The invention relates to the use of branched maltodextrins for inducing lysis of the cell walls of eukaryotic organisms having a polysaccharide wall in the lumen of the intestine of an omnivorous or carnivorous animal comprising an intestinal flora and also for synergistically increasing the effect of the branched maltodextrins in the induction of the growth of the intestinal flora of an omnivorous or carnivorous animal. The invention also relates to the composition intended for this use and to a method for improving health or for food supplementation.Type: ApplicationFiled: July 20, 2009Publication date: May 12, 2011Applicant: ROQUETTE FRERESInventors: Laetitia Deremaux, Daniel Wils
-
Patent number: 7935360Abstract: The invention concerns the application of compositions of micro-organisms in biological control of vine cryptogamic diseases. Said composition comprises a mixture of at least one bacterium and at least one yeast, the bacterium or bacteria and the yeast(s) being non-toxic for the plant. The invention also concerns bacterial and yeast strains, as well as biofungicide formulations containing an efficient amount of at least one composition of micro-organisms including in mixture at least one bacterium and one yeast, the bacterium or bacteria and the yeast(s) being non-toxic for the plant, and a composition of filamentous fungi, in particular of the genus Pichia, Pythium, Trichoderma, Gliocladium, Ampelomyces, Talaromyces, Epicococcum, combined with an inert carrier. The invention is useful for treating cryptogamic plant diseases, in particular crop plants and vine.Type: GrantFiled: July 1, 2003Date of Patent: May 3, 2011Assignee: Universite de BourgogneInventor: Bernard Paul
-
Patent number: 7923598Abstract: The invention provides isolated nucleic acid molecules which encode novel fatty acid hydroxylases. The invention also provides recombinant expression vectors including hydroxylase nucleic acid molecules, host cells into which the expression vectors have been introduced, and methods for the production of hydroxyl fatty acids such as 12-hydroxyoctadec-9-enoic acid (ricinoleic acid).Type: GrantFiled: June 22, 2007Date of Patent: April 12, 2011Assignees: Bioriginal Food & Science Corp., University of SaskatchewanInventors: Dauenpen Meesapyodsuk, Xiao Qiu
-
Publication number: 20110052538Abstract: This invention pertains to a method of promoting gastrointestinal health by ingesting a composition comprising one or more probiotic microorganisms, one or more carbohydrate sources, and one or more resistant protein products. Large intestinal health is benefited by one or more of the following: increased fecal weight, lower fecal pH, increased carbohydrate fermentation, and amelioration of protein fermentation.Type: ApplicationFiled: October 18, 2010Publication date: March 3, 2011Applicant: BRUNOB II B.V.Inventors: Ian Lewis Brown, Anne M. Birkett, Richard Le Leu, Graeme P. Young
-
Publication number: 20110033432Abstract: Compositions are provided that improve overall plant vigor and yield by combining agriculturally effective amounts of at least one environmentally friendly biological control agent and at least one chemical insect control agent. A composition of the present invention is particularly effective in the presence of fungal species. Use of a composition of the present invention leads to an overall reduction in crop losses caused by fungi and this reduction is much greater than would have been expected from application of either component alone. Methods for utilizing compositions of the present invention are also provided. Further the compositions according to this invention display a synergistic insecticidal, nematicidal, acaricidal or fungicidal activity.Type: ApplicationFiled: June 24, 2010Publication date: February 10, 2011Applicant: Bayer CropScience AGInventors: Peter Howard Davies, Andreas Görtz, Dirk Ebbinghaus, Stephane Carbonne
-
Publication number: 20110033433Abstract: Compositions are provided that improve overall plant vigor and yield by combining agriculturally effective amounts of at least one environmentally friendly biological control agent and at least one chemical fungicide. A composition of the present invention is particularly effective in the presence of fungal species. Use of a composition of the present invention leads to an overall reduction in crop losses caused by fungi and this reduction is much greater than would have been expected from application of either component alone. Methods for utilizing compositions of the present invention are also provided. Further the compositions according to this invention display synergistic insecticidal and/or fungicidal activity.Type: ApplicationFiled: June 24, 2010Publication date: February 10, 2011Applicant: Bayer CropScience AGInventors: Peter Howard Davies, Dirk Ebbinghaus, Andreas Görtz, Stephane Carbonne
-
Publication number: 20110014248Abstract: The present invention relates to a use of an effective amount of at least one probiotic microorganism and/or a fraction thereof and/or a metabolite thereof for preventing and/or treating dandruff disorders of the scalp, as well as a cosmetic process for preventing and/or treating a dandruff condition including the administration a first cosmetic active agent and of at least a second cosmetic active agent, topically, the said first and second cosmetic active agents being formulated in separate compositions, the first cosmetic active agent being chosen from probiotic microorganisms, and mixtures thereof, and the second cosmetic active agent being chosen from antidandruff active agents.Type: ApplicationFiled: March 15, 2010Publication date: January 20, 2011Applicants: L'OREAL, NESTEC SAInventors: Isabelle Castiel, Audrey Gueniche
-
Publication number: 20110014278Abstract: The invention relates to a composition comprising revivable dehydrated micro-organisms. The invention is characterised in that it further comprises particles at least 50% of which have a mean diameter greater than 250 ?m. The invention is applicable, in particular, to human or veterinary pharmaceuticals, to dietetics or to food products.Type: ApplicationFiled: February 6, 2006Publication date: January 20, 2011Applicant: VIRBAC SAInventor: Guy Derrieu
-
Publication number: 20110002900Abstract: The present invention relates in general to medium chain dicarboxylic acids, their derivatives and their uses. In particular, the present invention relates to a composition comprising medium chain dicarboxylic acids and to the use of medium chain dicarboxylic acids and their derivatives for the preparation of products to treat or prevent metabolic disorders. The composition of the present invention can particularly well be used to treat or prevent hyperglycemia, for example diabetes.Type: ApplicationFiled: March 9, 2009Publication date: January 6, 2011Inventors: Geltrude Mingrone, Catherine Mace
-
Publication number: 20100330055Abstract: Infection of pathogens is controlled by inducing disease resistance with a method of treating a plant with a composition of an acidic heat-treated solution of microorganisms.Type: ApplicationFiled: July 9, 2010Publication date: December 30, 2010Inventors: Daisuke Igarashi, Taito Takeda, Takashi Ishizaki, Kazuhiko Totsuka
-
Publication number: 20100303777Abstract: Delivery of binding molecules, such as antibodies, antibody fragments, single antibody variable domains, soluble receptors, ligands and dominant negative variants, to induce an immunomodulation in a patient is disclosed. More specifically, a medicament which includes micro-organisms which produce the binding molecules is described for the treatment of immune mediated diseases.Type: ApplicationFiled: December 12, 2007Publication date: December 2, 2010Applicant: ActoGeniX N.V.Inventors: An De Creus, Pieter Rottiers
-
Publication number: 20100303778Abstract: The invention relates to novel yeast strains, to the yeasts resulting from these strains, to a composition containing at least one Saccharomyces cerevisiae yeast and/or derivatives of a yeast having a particular interest as a food additive and/or probiotic and/or functional food and/or neutraceutic and/or functional ingredient and/or cosmeceutical and/or pharmaceutical active agent. The invention also relates to the use of the same in human and/or animal nutrition, or for the treatment or prevention of inflammatory diseases.Type: ApplicationFiled: December 12, 2008Publication date: December 2, 2010Inventors: Jean-Luc Simon, Georges Pignede, Pascal Vandekerckove, Daniel Poulain, Pierre Desreumaux, Arlette Darfeuille-Michaud, Adeline Sivignon
-
Publication number: 20100291053Abstract: We describe a composition comprising a source of long chain polyunsaturated fatty acid, for example, docosahexaenoic acid (DHA), and a carotenoid, for example, astaxanthin and other nutrients for prophylactic and/or therapeutic use in the healing of trauma- and stress-induced inflammatory conditions.Type: ApplicationFiled: June 23, 2004Publication date: November 18, 2010Inventors: Diane Clayton, Rebecca Rutter
-
Publication number: 20100278793Abstract: The present invention relates to the cosmetic treatment of greasy skin and/or skin that tends to be greasy with a lysate of at least one microorganism of the genus Bifidobacterium species and/or a fraction thereof, as an active.Type: ApplicationFiled: October 28, 2009Publication date: November 4, 2010Applicant: L'OREALInventors: Audrey Gueniche, Isabelle Castiel, Dominique Bernard
-
Publication number: 20100272699Abstract: The invention concerns active substances modulating the expression of the receptors of the products of the POMC gene (MC-IR, MC-2R, and the ? opioid receptor), and possibly modulating the expression of POMC in cutaneous cells, notably to modulate the proliferation and differentiation of epidermal cells in order to re-epithelial, maintain innervation, irrigate the skin, or to fight against aging, or to modulate pigmentation independently or not of cutaneous aging. The invention also concerns a method of screening such active substances.Type: ApplicationFiled: June 6, 2008Publication date: October 28, 2010Applicant: BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S.Inventors: Sabine Pain, Colette Dezutter, Valerie Aandre, Corinne Reymermier, Isabelle Orly, Eric Perrier
-
Publication number: 20100254957Abstract: A biologically pure culture of a yeast of the species Pichia anomala (WRL-076). The yeast is identified as NRRL Y-30842 and is applied to a site containing a deleterious microorganism. Further disclosed is a growth medium for increasing the viablility of yeast organisms.Type: ApplicationFiled: July 21, 2009Publication date: October 7, 2010Applicant: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTUREInventor: SUI-SHENG T. HUA
-
Patent number: 7807144Abstract: This invention features a composition that includes a multiple-cell organism for use as food for an aquatic animal (e.g., a fish or a shrimp), and a single-cell organism fed to, and as a result, bioencapsulated by, the multiple-cell organism. The single-cell organism has been transformed to express a recombinant antigen that induces an immune response in the aquatic animal.Type: GrantFiled: October 21, 2004Date of Patent: October 5, 2010Assignee: Academia SinicaInventors: Huey-Lang Yang, John Han-You Lin, James Chein-Chih Yu
-
Publication number: 20100247503Abstract: The invention relates to a method for producing a dry solid composition which is effective in the biological control of Colletotrichum gloeosporioides, contains Rhodotorula minuta and has a shelf life of at least one year. The invention also relates to the resulting composition and to a method for using same as a biological control agent. The invention further relates to a dry solid composition containing Rhodotorula minuta with a shelf life of up to one year when refrigerated and a second biological control agent, Bacillus subtilis, which can be used to obtain anthracnose severity control levels equal to or greater than the levels achieved with larger doses of those used with the same control agents, when applied independently. Finally the invention describes a method for reducing weight loss during the post-harvest storage of mango.Type: ApplicationFiled: October 16, 2006Publication date: September 30, 2010Inventors: Enrique Galindo Fentanes, Leobardo Serrano Carreon, Jose Armando Carrillo Fasio, Raul Allende Molar, Raymundo Saul Garcia Estrada, Lizette Trujillo Robles, Martin Patino Vera
-
Publication number: 20100247501Abstract: A foodstuff, includes: an extract of a plant of genus Salacia; and a flavonoid, wherein 50% inhibition concentration (IC50 value) of sucrase is 300 ?g/ml or less.Type: ApplicationFiled: September 3, 2008Publication date: September 30, 2010Applicant: FUJIFILM CORPORATIONInventor: Kenji Ikeda
-
Patent number: 7799328Abstract: The present invention relates to a method of treating or preventing weight loss of patients with inflammatory bowel diseases comprising administering to said patients an effective amount of Saccharomyces boulardii.Type: GrantFiled: December 23, 2004Date of Patent: September 21, 2010Assignee: BiocodexInventors: Bernard Hublot, Herve Groux, Rene Levy, Marie-Emmanuelle Le Guern, Paul Bernasconi
-
Publication number: 20100226900Abstract: The invention provides compositions and methods for preventing and treating osteochondrosis and lameness by administration of supplemental boron containing compounds to animals and humans. The supplemental boron containing compounds are provided in animal feed compositions or as supplements for animal feed. Also provided by this invention are animal feed compositions that are supplemented with boron containing compounds and which have reduced phosphorus content. The invention also provides a method for decreasing the amount of phosphorus excreted by an animal, a method of increasing the efficiency of absorption of phosphorus by an animal, a method of reducing environmental phosphorus pollution by administering supplemental boron to the animal. The invention also provides a method of reducing pre-weaning mortality in an animal by feeding pregnant, nursing or lactating animals by administering supplemental boron containing compounds.Type: ApplicationFiled: December 6, 2006Publication date: September 9, 2010Applicant: U.S. Borax Inc.Inventor: Edgar W. Johnson
-
Publication number: 20100221303Abstract: The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide a porous scaffold obtainable by the method as above described, and its use for tissue engineering, cell culture and cell delivery. The method of the invention comprises the steps consisting of: a) preparing an alkaline aqueous solution comprising an amount of at least one polysaccharide, an amount of a cross-linking agent and an amount of a porogen agent b) transforming the solution into a hydrogel by placing said solution at a temperature from about 4° C. to about 80° C. for a sufficient time to allow the cross-linking of said amount of polysaccharide and c) submerging said hydrogel into an aqueous solution d) washing the porous scaffold obtained at step c).Type: ApplicationFiled: October 10, 2008Publication date: September 2, 2010Applicants: UNIVERSITE PARIS 7 - DENIS DIDEROT, RECHERCHE MEDICALE)Inventors: Catherine Le Visage, Didier Letourneur
-
Publication number: 20100209407Abstract: The invention concerns active substances modulating the expression of the receptors of the products of the POMC gene (MC-IR, MC-2R, and the ? opioid receptor), and possibly modulating the expression of POMC in cutaneous cells, notably to modulate the proliferation and differentiation of epidermal cells in order to re-epithelial, maintain innervation, irrigate the skin, or restore normal pigmentation, or to fight against aging, or to modulate pigmentation independently or not of cutaneous aging. The invention also concerns a method of screening such active substances.Type: ApplicationFiled: June 6, 2008Publication date: August 19, 2010Applicant: BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S.Inventors: Sabine Pain, Colette Dezutter, Valerie Andre, Corinne Reymermier, Isabelle Orly, Eric Perrier
-
Patent number: 7754204Abstract: Secondary bile acid production inhibitors and cholesterol-lowering agents containing a yeast as the active ingredient.Type: GrantFiled: May 22, 2008Date of Patent: July 13, 2010Assignee: Kabushiki Kaisha Yakult HonshaInventors: Haruji Sawada, Yasuto Yoshida, Yasue Wada, Kenji Ohishi, Masahiko Itoh, Wakae Yokoi, Tsunekazu Watanabe
-
Patent number: 7736642Abstract: The invention provided herein relates to vaccines that can be tailored to achieve a desired immune response. Some compositions provided herein are used for preferentially eliciting a humoral immune response while other compositions are useful for preferentially eliciting a cell-mediated response. Combinations of vaccine compositions are also useful for eliciting both types of responses and/or for modulating the type of immune response elicited. The invention also provides methods for eliciting an immune response in an individual by administering the compositions disclosed herein. These immune responses are useful for protecting an individual from various types of diseases, infections, and undesirable conditions.Type: GrantFiled: February 2, 2007Date of Patent: June 15, 2010Assignee: GlobeImmune, Inc.Inventors: Richard C. Duke, Alex Franzusoff, Aurelia Haller, Thomas H. King, Yingnian Lu, Victoria Kelley Hodson
-
Publication number: 20100135971Abstract: The present invention relates generally to the field of nutrition, more particularly to the use of probiotics in nutrition. In particular the present invention relates to the use of a probiotic or of a mixture of probiotics in the manufacture of a nutritional composition or a medicament to act the colon in a pre- or post surgical environment.Type: ApplicationFiled: May 14, 2008Publication date: June 3, 2010Applicant: NESTEC S.A.Inventor: Eduardo Schiffrin
-
Publication number: 20100129413Abstract: A method for treatment of a viral infection in a mammal comprising a step of administering a composition containing an amount of selenium (Se) effective to raise the serum level of the mammal to at least 15 ?g/L above baseline.Type: ApplicationFiled: December 19, 2007Publication date: May 27, 2010Applicant: NUTRITION 21, INC.Inventors: James Komorowski, Barry Hurwitz
-
Publication number: 20100129324Abstract: The present invention relates to compositions of rosmarinic acid or its derivatives and to the use of a hydrolytic enzyme or of microorganism containing or producing hydrolytic enzymes in these compositions. The invention also pertains to methods for improving the biological effects of the rosemary extracts and for administering such compositions to a human or animal subject for improving the skin, coat, hair or health of the subject.Type: ApplicationFiled: November 6, 2007Publication date: May 27, 2010Inventors: Vanessa Crespy, Isabelle Castiel, Rachid Bel-Rhlid, Nicolas Page, Thomas Raab
-
Publication number: 20100129338Abstract: The present invention relates to the use of a combination of potato preparation and yeast for improving the attractiveness of molluscicidal compositions for slugs and snails. It also relates to corresponding compositions, to processes for the preparation of these compositions, and to their use for controlling terrestrial slugs and snails.Type: ApplicationFiled: May 9, 2008Publication date: May 27, 2010Inventors: Wolfgang WIRTH, Michael KILIAN
-
Patent number: 7704494Abstract: A method for producing plant protection or plant-strengthening agent for fighting against bacterial and/or fungal plant diseases, in particular against a fire blight consisting in adding capable to proliferate fungal structures into an acid medium for treating plants.Type: GrantFiled: September 14, 2004Date of Patent: April 27, 2010Assignee: Bio-Protect GmbHInventor: Stefan Kunz
-
Publication number: 20100092440Abstract: The present invention relates to a composition for the administration of biologically active substances in a gynaecologic and rectal ambit, as well as the uses of said composition. Said composition presents particularly favourable technological and stability characteristics of the end product, above all with regard to the viscosity after the dissolution/resuspension of the same in a hydrophilic liquid medium which allows a better adhesion and a direct contact from bacteria to the treated mucosae. Said composition includes a specific viscosizing agent selected from the group of the gums, which can play an important prebiotic function by contributing in a significant way to the correct growth and colonization of the probiotic culture, thus forming a perfect symbiotic system.Type: ApplicationFiled: November 12, 2007Publication date: April 15, 2010Applicant: PROBIOTICAL S.P.A.Inventors: Gian Paolo Strozzi, Luca Mogna
-
Publication number: 20100061968Abstract: A method of reducing the cholesterol level of a subject by administering to that subject quercetin, vitamin C, vitamin B3, and statin.Type: ApplicationFiled: September 5, 2008Publication date: March 11, 2010Inventor: Thomas Christian Lines
-
Publication number: 20100047320Abstract: The present invention relates to an oral formulation to lower serum or hepatic lipid and triglyceride concentrations, hepatic inflammation and/or insulin resistance in a patient comprising live feruloyl esterase producing microorganisms alone or in association with a pharmaceutically acceptable carrier resistant to gastric conditions, and wherein the microorganisms are wild type, genetically modified, or combination thereof.Type: ApplicationFiled: September 7, 2007Publication date: February 25, 2010Inventors: Satya Prakash, Jasmine Rohinton Bhathena
-
Publication number: 20100047219Abstract: An extract of the marine algae, Sarcodiotheca, and more particularly Sarcodiotheca gaudichaudii, is described for use in cosmetic compositions. A biofermentation of Sarcodiotheca, such as for example S. gaudichaudii, is also described. This marine bioferment is useful as a skin care active ingredient for anti-aging cosmetic applications, and particularly useful when used in combination with an extracts of red algae, such as Chondrus crispus.Type: ApplicationFiled: September 26, 2007Publication date: February 25, 2010Applicant: BASF BEAUTY CARE SOLUTIONS LLCInventors: Joseph D. Ceccoli, Brian Costello, Sreekumar Pillai
-
Publication number: 20100034840Abstract: Provided herein are cells, vectors and viruses in association with a mutant polypeptide that has emerged in response to a therapeutic or prophylactic agent; compositions comprising such cells, vectors and viruses and methods for their use in eliciting an immune response to the mutant polypeptide. In some examples, the immune response is a cellular immune response.Type: ApplicationFiled: July 10, 2006Publication date: February 11, 2010Inventors: David Apelian, Alex Franzusoff, Timothy C. Rodell
-
Publication number: 20100028316Abstract: The present invention relates to the use of an oral composition comprising yeast extract, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.Type: ApplicationFiled: June 12, 2009Publication date: February 4, 2010Applicant: Nestec S.A.Inventors: Irène Corthesy-Theulaz, Grigorios Fotopoulos, Gabriela Bergonzelli
-
Publication number: 20100028315Abstract: Disclosed are dried and/or microencapsulated Saccharomyces cerevisiae cells with a high content of (S)-(+)-S-adenosyl-L-methionine, in the form of a free base obtainable from selected high-productivity strains of (S)-(+)-SAMe.Type: ApplicationFiled: June 9, 2006Publication date: February 4, 2010Inventors: Alberto Benedetti, Lino Sivieri
-
Patent number: 7651680Abstract: Compositions for preventing and/or treating sensitive and/or dry skin include at least an effective amount of at least one agent and at least an effective amount of at least one divalent inorganic cation, wherein the at least one agent includes at least one member selected from the group consisting of at least one microorganism, a fraction of the at least one microorganism and a metabolite of the at least one microorganism. Methods for preparing such compositions and cosmetic treatment methods employing such compositions are also provided.Type: GrantFiled: June 23, 2005Date of Patent: January 26, 2010Assignees: L'Oreal, Nestec S.A.Inventors: Lionel Breton, Roland Jourdain, Audrey Gueniche, Isabelle Bureau-Franz, Stephanie Blum-Sperisen
-
Patent number: 7648698Abstract: The present invention relates to a novel vaccine, its use for immunoprophylaxis and/or the treatment of candidamycoses in human and veterinary medicine as well as methods for its preparation, wherein said vaccine consists of the combination of the Candida strains a1) Candida albicans CCM 8355 a2) Candida glabrata CCM 8356 a3) Candida krusei CCM 8357 and a4) an immunomudulating Propionibacterium acnes strain, and optionally pharmaceutically acceptable excipients, such as carriers, wherein the ratio of the components a1-a4 in the end product is a1:a2:a3:a4 is 10-20:10-20:10-20:40-70.Type: GrantFiled: September 23, 2005Date of Patent: January 19, 2010Assignee: Bioveta AGInventors: Dagmar Braun, Vladimir Vrzal, Libor Bittner, Dagmar Koukalova
-
Patent number: 7632511Abstract: Disclosed are compositions, including vaccines, and methods for vaccinating an animal against hepatitis C virus (HCV) and for treating or preventing hepatitis C viral infection in an animal. The invention includes a variety of novel HCV fusion proteins that can be used directly as a vaccine or in conjunction with a yeast-based vaccine vehicle to elicit an immune response against HCV in an animal. The invention also includes the use of the HCV fusion gene and protein described herein in any diagnostic or therapeutic protocol for the detection and/or treatment or prevention of HCV infection.Type: GrantFiled: December 31, 2006Date of Patent: December 15, 2009Assignee: GlobeImmune, Inc.Inventors: Richard C. Duke, Alex Franzusoff, Aurelia Haller, Thomas H. King
-
Publication number: 20090297618Abstract: The present invention provides a formula food comprising lutien, zeaxanthin, zinc, and selenium beneficial for eye health and its application. The formula food is not only applied for dietary supplement tablets and capsules, but also applied for various formula milk powders, various functional beverages, various baked food. The formula food is conducive to the human eye health, especially beneficial for the improvement of visuognosis persistence of human eyes, helpful for asthenopia remission and the improvement of eye consciousness symptoms.Type: ApplicationFiled: May 28, 2009Publication date: December 3, 2009Inventors: Xinde Xu, Di Zhou, Lihua Zhang, Bin Shao
-
Patent number: 7625569Abstract: Disclosed are compositions, including vaccines, and methods for vaccinating an animal against hepatitis C virus (HCV) and for treating or preventing hepatitis C viral infection in an animal. The invention includes a variety of novel HCV fusion proteins that can be used directly as a vaccine or in conjunction with a yeast-based vaccine vehicle to elicit an immune response against HCV in an animal. The invention also includes the use of the HCV fusion gene and protein described herein in any diagnostic or therapeutic protocol for the detection and/or treatment or prevention of HCV infection.Type: GrantFiled: December 31, 2006Date of Patent: December 1, 2009Assignee: GlobeImmune, Inc.Inventors: Richard C. Duke, Alex Franzusoff, Aurelia Haller, Thomas H. King